385 related articles for article (PubMed ID: 19457134)
21. Tumor necrosis factor receptor 1 induces interleukin-6 upregulation through NF-kappaB in a rat neuropathic pain model.
Lee KM; Jeon SM; Cho HJ
Eur J Pain; 2009 Sep; 13(8):794-806. PubMed ID: 18938092
[TBL] [Abstract][Full Text] [Related]
22. [Different enzymatic activities recruitment by specific domains of TIF2 are involved in NF-kappaB transactivation].
Nojek IM; Werbajh SE; Colo GP; Rubio FM; Franco LD; Nahmod VE; Costas MA
Medicina (B Aires); 2004; 64(2):135-8. PubMed ID: 15628300
[TBL] [Abstract][Full Text] [Related]
23. Surfactin inhibits immunostimulatory function of macrophages through blocking NK-kappaB, MAPK and Akt pathway.
Park SY; Kim Y
Int Immunopharmacol; 2009 Jul; 9(7-8):886-93. PubMed ID: 19336264
[TBL] [Abstract][Full Text] [Related]
24. The flavonoid, fisetin, inhibits UV radiation-induced oxidative stress and the activation of NF-kappaB and MAPK signaling in human lens epithelial cells.
Yao K; Zhang L; Zhang Y; Ye P; Zhu N
Mol Vis; 2008; 14():1865-71. PubMed ID: 18949064
[TBL] [Abstract][Full Text] [Related]
25. Celecoxib potently inhibits TNFalpha-induced nuclear translocation and activation of NF-kappaB.
Funakoshi-Tago M; Shimizu T; Tago K; Nakamura M; Itoh H; Sonoda Y; Kasahara T
Biochem Pharmacol; 2008 Sep; 76(5):662-71. PubMed ID: 18644347
[TBL] [Abstract][Full Text] [Related]
26. Nuclear factor-kappa B nuclear translocation in the cochlea of mice following acoustic overstimulation.
Masuda M; Nagashima R; Kanzaki S; Fujioka M; Ogita K; Ogawa K
Brain Res; 2006 Jan; 1068(1):237-47. PubMed ID: 16376312
[TBL] [Abstract][Full Text] [Related]
27. Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid.
Karunakaran S; Diwakar L; Saeed U; Agarwal V; Ramakrishnan S; Iyengar S; Ravindranath V
FASEB J; 2007 Jul; 21(9):2226-36. PubMed ID: 17369508
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional down-regulation of thromboxane A(2) receptor expression via activation of MAPK ERK1/2, p38/NF-kappaB pathways.
Zhang W; Zhang Y; Edvinsson L; Xu CB
J Vasc Res; 2009; 46(2):162-74. PubMed ID: 18769070
[TBL] [Abstract][Full Text] [Related]
29. Epigallocatechin gallate inhibits phorbol ester-induced activation of NF-kappa B and CREB in mouse skin: role of p38 MAPK.
Kundu JK; Surh YJ
Ann N Y Acad Sci; 2007 Jan; 1095():504-12. PubMed ID: 17404063
[TBL] [Abstract][Full Text] [Related]
30. Proteomic analysis of the neuroprotective mechanisms of acupuncture treatment in a Parkinson's disease mouse model.
Jeon S; Kim YJ; Kim ST; Moon W; Chae Y; Kang M; Chung MY; Lee H; Hong MS; Chung JH; Joh TH; Lee H; Park HJ
Proteomics; 2008 Nov; 8(22):4822-32. PubMed ID: 18942673
[TBL] [Abstract][Full Text] [Related]
31. NFAT5 induction and its role in hyperosmolar stressed human limbal epithelial cells.
Lee JH; Kim M; Im YS; Choi W; Byeon SH; Lee HK
Invest Ophthalmol Vis Sci; 2008 May; 49(5):1827-35. PubMed ID: 18436816
[TBL] [Abstract][Full Text] [Related]
32. Polyglutamine-expanded ataxin-7 decreases nuclear translocation of NF-kappaB p65 and impairs NF-kappaB activity by inhibiting proteasome activity of cerebellar neurons.
Wang HL; He CY; Chou AH; Yeh TH; Chen YL; Li AH
Cell Signal; 2007 Mar; 19(3):573-81. PubMed ID: 17005371
[TBL] [Abstract][Full Text] [Related]
33. Microarray analyses of the effects of NF-kappaB or PI3K pathway inhibitors on the LPS-induced gene expression profile in RAW264.7 cells: synergistic effects of rapamycin on LPS-induced MMP9-overexpression.
Mendes Sdos S; Candi A; Vansteenbrugge M; Pignon MR; Bult H; Boudjeltia KZ; Munaut C; Raes M
Cell Signal; 2009 Jul; 21(7):1109-22. PubMed ID: 19285553
[TBL] [Abstract][Full Text] [Related]
34. Activation of NF-kappaB is involved in 6-hydroxydopamine-but not MPP+ -induced dopaminergic neuronal cell death: its potential role as a survival determinant.
Park SH; Choi WS; Yoon SY; Ahn YS; Oh YJ
Biochem Biophys Res Commun; 2004 Sep; 322(3):727-33. PubMed ID: 15336524
[TBL] [Abstract][Full Text] [Related]
35. Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation.
Dehmer T; Heneka MT; Sastre M; Dichgans J; Schulz JB
J Neurochem; 2004 Jan; 88(2):494-501. PubMed ID: 14690537
[TBL] [Abstract][Full Text] [Related]
36. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
Liu LX; Chen WF; Xie JX; Wong MS
Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
[TBL] [Abstract][Full Text] [Related]
37. Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP.
Song DD; Shults CW; Sisk A; Rockenstein E; Masliah E
Exp Neurol; 2004 Apr; 186(2):158-72. PubMed ID: 15026254
[TBL] [Abstract][Full Text] [Related]
38. Hesperidin inhibited acetaldehyde-induced matrix metalloproteinase-9 gene expression in human hepatocellular carcinoma cells.
Yeh MH; Kao ST; Hung CM; Liu CJ; Lee KH; Yeh CC
Toxicol Lett; 2009 Feb; 184(3):204-10. PubMed ID: 19110045
[TBL] [Abstract][Full Text] [Related]
39. Attenuation of MPTP-induced neurotoxicity and locomotor dysfunction in Nucling-deficient mice via suppression of the apoptosome pathway.
Teng X; Sakai T; Liu L; Sakai R; Kaji R; Fukui K
J Neurochem; 2006 May; 97(4):1126-35. PubMed ID: 16686692
[TBL] [Abstract][Full Text] [Related]
40. Chemokines in the MPTP model of Parkinson's disease: absence of CCL2 and its receptor CCR2 does not protect against striatal neurodegeneration.
Kalkonde YV; Morgan WW; Sigala J; Maffi SK; Condello C; Kuziel W; Ahuja SS; Ahuja SK
Brain Res; 2007 Jan; 1128(1):1-11. PubMed ID: 17126305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
